Juvenescence News Releases

BHB Therapeutics

Juvenescence and the Buck Institute launch BHB Therapeutics

Juvenescence and the Buck Institute for Research on Aging announce a new collaboration with the formation of BHB Therapeutics a joint venture.

February 4, 2019

Juvenescence

Juvenescence closes First $46M Tranche of $100M Series B

Juvenescence is pleased to announce the close of the first tranche of its Series B financing, in the amount of $46 million.

January 16, 2019

Napa Therapeutics

Juvenescence, The Buck Institute, and Insilico Medicine establish Napa Therapeutics

Juvenescence, The Buck Institute for Research on Aging, and Insilico Medicine announced today that they have formed Napa Therapeutics, to develop drugs against a novel aging-related target.

August 14, 2018

Juvenescence

Juvenescence Series A, Nets $50 Million

Juvenescence has successfully raised $50 million in its Series A financing. The Series A financing was oversubscribed with participation from founders, insiders, institutional investors and family offices.

June 11, 2018

Juvenescence

Karim Hakimzadeh Appointed to Board of Directors

Juvenescence announced the appointment of Karim Hakimzadeh to its Board of Directors. The appointment increases the size of the Board of Directors to five members.

February 13, 2018

Juvenescence

Juvenescence Closes Seed Round of USD $12.3 Million with Participation from Seasoned Biotech Investors

Juvenescence announced that it has closed its seed funding round, raising USD $12.3 million. The Seed Round was included undisclosed sums from a range of seasoned international angel investors and institutions.

January 8, 2018